International Clinical Trial: Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526051) titled 'Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome' on April 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Foundation University Islamabad

Condition: Lower Cross Syndrome

Intervention: Procedure: Autogenic Inhibition (PFS) Group A

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: April 7, 2026

Target Sample Size: 72

Countries of Recruitment: Pakistan

To know more, visit https://clinicaltrials.gov/st...